Difference between revisions of "Novartis"
(changed title 'Corporate Services' to 'Business Intelliegence') |
(PR) |
||
Line 2: | Line 2: | ||
*[[APCO Worldwide]] | *[[APCO Worldwide]] | ||
− | + | Novartis is listed as a client for [[Business Insights]]<ref> Business Insights [http://globalbusinessinsights.com/content/rbhc0019m.pdf Patient Power: The shift towards more informed, more powerful consumers of drugs] Accessed 5th February 2008</ref> | |
+ | |||
+ | In 2008, Novartis is listed as a client of [[Innovex]]<ref> Innovex [http://www.innovexcareers.com/content_static/c_ourcustomers.asp?session_id={212F403D-EE9F-433B-A03A-E66AB35FB45E} Our Customers] Accessed 12th February 2008</ref> | ||
==Affiliations== | ==Affiliations== |
Revision as of 18:52, 12 February 2008
PR, Lobbying and Business Intelligence firms
Novartis is listed as a client for Business Insights[1]
In 2008, Novartis is listed as a client of Innovex[2]
Affiliations
Novartis provided generous support for the Expert Consensus Guideline Series: Treatment of Schizophrenia 1999 an initiative aiming at establishing uniform medication guidelines for schizophrenia[3]. It is reported that this was an initiative 'supported exclusively by 6 pharmaceutical companies: Eli Lilly and Company, Janssen Pharmaceutica Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Pharmaceutical, Pfizer Inc. and Zeneca Pharmaceuticals' (now known as AstraZeneca). Michael Hogan and Laurie Flynn were also involved in this initiative.
References
- ↑ Business Insights Patient Power: The shift towards more informed, more powerful consumers of drugs Accessed 5th February 2008
- ↑ Innovex Our Customers Accessed 12th February 2008
- ↑ Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008